Evidence map›Paper›PMID 39677870›Full record

ArticleClinical case reports2024

Ductal Carcinoma In Situ of the Breast in Sclerosing Adenosis Mimicking Microinvasive Ductal Carcinoma: A Rare Case Report.

Yu-Kai Chang, Yuan-Yuei Chen, Zhi-Jie Hong, Guo-Shiou Liao, Jyh-Cherng Yu

Abstract read
In one paragraph

Article in Clinical case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yu-Kai ChangDepartment of Surgery Tri-Service General Hospital, National Defense Medical Center Taipei Taiwan.
Yuan-Yuei ChenDepartment of Pathology Tri-Service General Hospital, National Defense Medical Center Taipei Taiwan.
Zhi-Jie HongDivision of Traumatology, Department of Surgery Tri-Service General Hospital, National Defense Medical Center Taipei Taiwan.
Guo-Shiou LiaoDivision of General Surgery, Department of Surgery Tri-Service General Hospital, National Defense Medical Center Taipei Taiwan.
Jyh-Cherng YuDivision of General Surgery, Department of Surgery Tri-Service General Hospital, National Defense Medical Center Taipei Taiwan.ORCID https://orcid.org/0009-0004-8298-0790

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sclerosing adenosis (SA) is a subtype of adenosis characterized by proliferative adenosis and stromal sclerosis with distortion of the terminal ductal lobular unit. Although SA is the most prevalent benign breast condition among middle-aged women, it may be associated with a two-fold increase in breast cancer risk. Microscopic findings of ductal carcinoma in situ (DCIS) in a SA (SA-DCIS) may mimic microinvasive carcinoma or even invasive carcinoma, which may result in overtreatment by a breast surgeon. Therefore, pathological evaluation must be performed carefully in such cases to establish a definitive diagnosis. Herein, we present a rare case of SA-DCIS that mimicked microinvasive ductal carcinoma. A 51-year-old woman was diagnosed with high-grade DCIS of the left breast, highly suspicious for microinvasion, based on core biopsy. She underwent mastectomy of the left breast and prophylactic mastectomy of the right breast for personal reasons after imaging evaluation, including mammography and ultrasonography. However, the final diagnosis was bilateral intermediate-grade DCIS, characterized by the presence of intraductal carcinoma cells exhibiting enlarged hyperchromatic nuclei and a high nuclear-to-cytoplasmic ratio within the mammary ducts. However, the diagnosis was incompatible with the initial pathological results. A-DCIS has pathological features similar to those of microinvasive or invasive carcinomas. Thoroughly evaluating biopsy findings of lesions to distinguish between SA-DCIS and invasive carcinoma is crucial to prevent overdiagnosis and unnecessary management in patients with DCIS. Patients diagnosed with SA-DCIS are at a higher risk of developing bilateral breast cancer than those without SA-DCIS.

Indexed as

breast cancercase reportductal carcinoma in situhistochemical stainsSclerosing adenosis

Identifiers

PMID39677870
PMCPMC11638370

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.